Founder and CEO, Curley Global IR, LLC
Sally is a 30+ year corporate executive, Board Director, author, angel investor and successful entrepreneur. She has built and led corporate sustainability, investor relations and governance engagement programs for Fortune 500 public companies such as Cardinal Health and Genzyme Corporation (now Sanofi Aventis), in addition to smaller public and private companies. She has extensive expertise in risk assessment, governance and capital market strategy – including execution for complex IPOs, spin-offs, divestitures and acquisitions. As a confidante to public and private company directors and C-suite, Sally has partnered to facilitate leadership transition, talent identification and development, and manage crises, including shareholder activism. She currently serves on the Advisory Board of a life science tools company, is former Board Chair and current Director of a global NGO and serves as Board Director for a national angel investing group.
Sally’s industry expertise extends beyond healthcare, to include aerospace, automotive, building materials, financial services, industrial components and real estate. Sally has lived and worked abroad; she and her husband enjoy visiting family and friends in the U.K. and EU.